Skip to Content

ConvaTec Group PLC

CTEC: XLON (GBR)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
GBX 514.00XwqwdnfMqqjvyz

ConvaTec Remains On Track to Reach Our Full-Year Estimates; No Change to Our Fair Value Estimate

Narrow-moat ConvaTec released year-to-date revenue growth (covering the first 10 months of 2022) that generally matched our assumptions for the full year. After making slight adjustments for unfavorable foreign currency exchange that were offset by cash flows realized since our last update, we’re holding steady on our fair value estimate.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of CTEC so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center